New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

The Covid-19 mRNA-based vaccines that saved 2.5 million lives globally in the pandemic could help spark the immune system to ...

Lung and skin cancer patients who were taking "checkpoint inhibitors" and had the COVID vaccine saw surprising results.

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

COVID-19 mRNA vaccines may enhance the effects of immunotherapy drugs in cancer patients, potentially improving survival rates.

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment.

Advanced lung and skin cancer patients lived substantially longer when vaccinated early during immunotherapy The findings suggest the vaccine's mRNA molecule acts as an immune boost to help fight ...

Moderna (MRNA) just began dosing patients in a Phase 1/2 study of mRNA-2808, its experimental T-cell therapy for advanced multiple myeloma. This effort highlights Moderna's growing emphasis on cancer ...

Researchers can use messenger RNA to trigger the immune system to attack tumors. By stimulating cancer cells to produce a ...